Optical coherence tomography and visual field testing both essential

Article

Both structural and functional testing are important when diagnosing glaucoma and managing the condition in patients who have the disease.

"The question of imaging versus visual fields in glaucoma is a tongue-in-cheek discussion to some degree," Dr. Wooldridge said. "You really need both."

Visual field testing (VFT) using standard automated perimetry faces several "charges" in some quarters, in that VFT:

Advances in perimetry, such as short wavelength automated perimetry (SWAP) and frequency doubling technology, have increased sensitivity compared with standard automated perimetry. These newer technologies allow optometrists to detect VFL earlier in the disease process. They also utilize stimuli and patterns of presentation that target and allow the monitoring of select subpopulations of retinal ganglion cells.

In addition, improvements in software allow test times to be halved, reducing patient fatigue and increasing the reliability of the results, Dr. Wooldridge said. In addition, achromatic VFTs are the primary measure of progression in more advanced disease.

No single "best" perimeter or VFT for the early detection of glaucomatous damage exists, Dr. Wooldridge said. Some patients' damage will be detected first by SWAP, some by FDT, and some by standard automated perimetry.

The importance of using imaging along with visual fields can't be overestimated because structural damage precedes functional change; nerve fiber layer injury can be observed up to 6 years before visual field defects become evident, as noted by Sommer, Katz, Quigley, et al.

Imaging via the current state-of-the-art spectral domain optical coherence tomography (OCT) provides information about the optic nerve head, ganglion cell complex, retinal nerve fiber layer (RNFL), and other structures, and it enables glaucoma progression analyses that include thickness maps, changes in optic disc parameters, temporal superior nasal inferior temporal graph comparisons, RNFL trend analysis, and changes in RNFL parameters.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
© 2025 MJH Life Sciences

All rights reserved.